Patent details
LUC00077 Product Name: Produit de combinaison pharmaceutique comprenant un sel pharmaceutiquement acceptable d'uméclidinium (par exemple le bromure d'uméclidinium), le vilantérol ou un de ses sels pharmaceutiquement acceptable (par exemple le trifénatate de vilantérol) et le furoate de fluticasone
Basic Information
- Publication number:
- LUC00077
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP107815276
- Legal Status:
- Inactive
- Application number:
- LUC00077
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/17/1236
- Marketing Authorization Type:
- Marketing Authorization Date:
- 17/11/2017
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 04/06/2018
- First Marketing Authorization date:
- 17/11/2017
- Grant date:
- 14/08/2018
- Activation date:
- Publication date:
- 07/06/2018
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 17/11/2032
- SPC Extension Expiration:
- 17/11/2032
- Rejection date:
- Withdrawal date:
Owner
- From:
- 16/04/2025
- Name:
- GLAXO GROUP LIMITED
- Address:
- GSK Medicines Research Centre; Gunnels Wood Road, SG1 2NY, Stevenage, United Kingdom (GB)
History of Owners
- From:
- 04/06/2018
- To:
- 16/04/2025
- Name:
- Glaxo Group Limited
- Address:
- 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 04/06/2018
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2018/08
- Publication date:
- 06/07/2018
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2018/10
- Publication date:
- 19/09/2018
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2025/07
- Publication date:
- 04/06/2025
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20250000122A
- Date Registered:
- 16/04/2025
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- ARONOVA S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- GLAXO GROUP LIMITED
- Address:
- GSK Medicines Research Centre; Gunnels Wood Road, SG1 2NY, Stevenage, United Kingdom (GB)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 02/12/2030
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 04/06/2018 | General Document | 3 |
| 14/08/2018 | Certificate | 1 |
| 04/06/2018 | Application Form | 4 |
| 04/06/2018 | General Document | 2 |
| 04/06/2018 | General Document | 41 |
| 07/06/2018 | Publication | 1 |
| 04/06/2018 | General Document | 3 |
| 14/08/2018 | Publication | 1 |
| 07/06/2018 | Outgoing Correspondence | 1 |
| 16/04/2025 | Request For Change | 3 |
| 12/05/2025 | Outgoing Correspondence | 2 |
| 17/04/2025 | General Document | 2 |